Real-World Effectiveness of Ensitrelvir in Reducing Severe Outcomes in Outpatients at High Risk for COVID-19
Takazono et al., Infectious Diseases and Therapy, doi:10.1007/s40121-024-01010-4
https://c19early.org/takazono.html